Heart, Lung and Circulation

Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot

Published:November 03, 2021DOI:


      Heart failure is increasing in prevalence, creating a greater public health and economic burden on our health care system. With a rising proportion of hospitalisations for heart failure with preserved ejection fraction (HFpEF) compared to heart failure with reduced ejection fraction (HFrEF) and lack of proven therapies for HFpEF, patient characterisation and defining clinical outcomes are important in determining optimal management of heart failure patients. There is scarce Australian-specific data with regards to the burden of disease of patients with HFpEF which further limits our ability to appropriately manage this syndrome.


      To determine the characteristics, management practices and outcomes of patients with HFpEF compared to patients diagnosed with HFrEF.


      Data was sourced from the Victorian Cardiac Outcomes Registry-Heart Failure (VCOR-HF) snapshot of patients admitted with acute heart failure to one of 16 Victorian health services between 2014–2017 over one consecutive month annually. Outcomes measured were in-hospital mortality, and 30-day readmission and mortality.


      Of the 1,132 HF patients, 436 patients were diagnosed with HFpEF and were more likely to be female (59%) and older (81.5±9.8 vs 73.2±14.5 years). They were also more likely to have hypertension (80%), atrial fibrillation (59.9%), chronic obstructive airways disease (36.2%) and chronic kidney disease (68.8%). Patients with HFrEF were more likely to have ischaemic heart disease with a history of previous myocardial infarction (36.6%), percutaneous coronary intervention and cardiac bypass surgery (35.2%). There were no significant differences in 30-day mortality between HFpEF and HFrEF (10.2% vs 7.8%; p=0.19, respectively) and 30-day readmission rates (22.1% vs 25.9%; p=0.15, respectively).


      VCOR-HF Snapshot data provides important insight into the burden of acute heart failure. Whilst patients with HFpEF and HFrEF have differing clinical profiles, morbidity, mortality and re-admission rates are similar.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Diez-Villanueva P.
        • Alfonso F.
        Heart failure in the elderly.
        J Geriatr Cardiol. 2016; 13: 115-117
        • Chan Y.K.
        • Tuttle C.
        • Ball J.
        • Teng T.K.
        • Ahamed Y.
        • Carrington M.J.
        • et al.
        Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue.
        BMC Health Serv Res. 2016; 16: 501
        • Australian Institute of Health and Welfare
        Australia’s Health 2018.
        (Australia’s health series no.16. AUS 221) AIHW, Canberra2018
        • Atherton J.J.
        • Sindone A.
        • De Pasquale C.G.
        • Driscoll A.
        • MacDonald P.S.
        • Hopper I.
        • et al.
        National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018.
        Med J Aust. 2018; 209: 363-369
        • Steinberg B.A.
        • Zhao X.
        • Heidenreich P.A.
        • Peterson E.D.
        • Bhatt D.L.
        • Cannon C.P.
        • et al.
        Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
        Circulation. 2012; 126: 65-75
        • Fonarow G.C.
        • Stough W.G.
        • Abraham W.T.
        • Albert N.M.
        • Gheorghiade M.
        • Greenberg B.H.
        • et al.
        Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
        J Am Coll Cardiol. 2007; 50: 768-777
        • Kaneko H.
        • Suzuki S.
        • Yajima J.
        • Oikawa Y.
        • Sagara K.
        • Otsuka T.
        • et al.
        Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken Database 2004-2011.
        J Cardiol. 2013; 62: 102-109
        • Bhatia R.S.
        • Tu J.V.
        • Lee D.S.
        • Austin P.C.
        • Fang J.
        • Haouzi A.
        • et al.
        Outcome of heart failure with preserved ejection fraction in a population-based study.
        N Engl J Med. 2006; 355: 260-269
        • Cheng R.K.
        • Cox M.
        • Neely M.L.
        • Heidenreich P.A.
        • Bhatt D.L.
        • Eapen Z.J.
        • et al.
        Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
        Am Heart J. 2014; 168: 721-730
        • Lenzen M.J.
        • Scholte op Reimer W.J.
        • Boersma E.
        • Vantrimpont P.J.
        • Follath F.
        • Swedberg K.
        • et al.
        Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.
        Eur Heart J. 2004; 25: 1214-1220
        • McCullough P.A.
        • Khandelwal A.K.
        • McKinnon J.E.
        • Shenkman H.J.
        • Pampati V.
        • Nori D.
        • et al.
        Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America.
        Congest Heart Fail. 2005; 11: 6-11
        • Senni M.
        • Redfield M.M.
        Heart failure with preserved systolic function. A different natural history?.
        J Am Coll Cardiol. 2001; 38: 1277-1282
        • Reddy Y.N.
        • Borlaug B.A.
        Heart failure with preserved ejection fraction.
        Curr Probl Cardiol. 2016; 41: 145-188
        • Butler J.
        • Fonarow G.C.
        • Zile M.R.
        • Lam C.S.
        • Roessig L.
        • Schelbert E.B.
        • et al.
        Developing therapies for heart failure with preserved ejection fraction: current state and future directions.
        JACC Heart Fail. 2014; 2: 97-112
        • Stub D.
        • Lefkovits J.
        • Brennan A.L.
        • Dinh D.
        • Brien R.
        • Duffy S.J.
        • et al.
        The establishment of the Victorian Cardiac Outcomes Registry (VCOR): monitoring and optimising outcomes for cardiac patients in Victoria.
        Heart Lung Circ. 2018; 27: 451-463
        • Driscoll A.
        • Dinh D.
        • Prior D.
        • Kaye D.
        • Hare D.
        • Neil C.
        • et al.
        The effect of transitional care on 30-day outcomes in patients hospitalised with acute heart failure.
        Heart Lung Circ. 2020; 9: 1347-1355
        • Marantz P.R.
        • Tobin J.N.
        • Wassertheil-Smoller S.
        • Steingart R.M.
        • Wexler J.P.
        • Budner N.
        • et al.
        The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria.
        Circulation. 1988; 77: 607-612
        • Owan T.E.
        • Hodge D.O.
        • Herges R.M.
        • Jacobsen S.J.
        • Roger V.L.
        • Redfield M.M.
        Trends in prevalence and outcome of heart failure with preserved ejection fraction.
        N Engl J Med. 2006; 355: 251-259
        • Gerber Y.
        • Weston S.A.
        • Redfield M.M.
        • Chamberlain A.M.
        • Manemann S.M.
        • Jiang R.
        • et al.
        A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.
        JAMA Intern Med. 2015; 175: 996-1004
        • Ather S.
        • Chan W.
        • Bozkurt B.
        • Aguilar D.
        • Ramasubbu K.
        • Zachariah A.A.
        • et al.
        Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.
        J Am Coll Cardiol. 2012; 59: 998-1005
        • Tribouilloy C.
        • Rusinaru D.
        • Mahjoub H.
        • Souliere V.
        • Levy F.
        • Peltier M.
        • et al.
        Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.
        Eur Heart J. 2008; 29: 339-347
        • Parmar K.R.
        • Xiu P.Y.
        • Chowdhury M.R.
        • Patel E.
        • Cohen M.
        In-hospital treatment and outcomes of heart failure in specialist and non-specialist services: a retrospective cohort study in the elderly.
        Open Heart. 2015; 2: e000095
        • Driscoll A.
        • Meagher S.
        • Kennedy R.
        • Hay M.
        • Banerji J.
        • Campbell D.
        • et al.
        What is the impact of systems of care for heart failure on patients diagnosed with heart failure: a systematic review.
        BMC Cardiovasc Disord. 2016; 16: 195
        • van Riet E.E.
        • Hoes A.W.
        • Limburg A.
        • Landman M.A.
        • van der Hoeven H.
        • Rutten F.H.
        Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion.
        Eur J Heart Fail. 2014; 16: 772-777
        • Savarese G.
        • Lund L.H.
        Global public health burden of heart failure.
        Card Fail Rev. 2017; 3: 7-11
        • Bursi F.
        • Weston S.A.
        • Redfield M.M.
        • Jacobsen S.J.
        • Pakhomov S.
        • Nkomo V.T.
        • et al.
        Systolic and diastolic heart failure in the community.
        JAMA. 2006; 296: 2209-2216